CORRESP 1 filename1.htm

cphicorresp080311.htm

China Pharma Holdings, Inc.

Second Floor, No. 17, Jinpan Road

Haikou, Hainan Province, China 570216

August 2, 2011

VIA EDGAR

Ms. Tabatha Akins

Staff Accountant

Division of Corporation Finance

Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

	Re:	China Pharma Holdings, Inc.
	Form 10-K for the fiscal year ended December 31, 2010
	Form 10-Q for the period ended March 31, 2011
	File No. 001-34471

Dear Ms. Akins:

Reference is hereby made to the above filings for China Pharma Holdings, Inc.   We  acknowledge receipt of the comment letter from the Securities and Exchange Commission (the “Commission”) dated July 25, 2011 (the “Comment Letter”).  We acknowledge and appreciate your confirmation to our legal counsel, Pryor Cashman LLP on August 2, 2011, that the Commission has granted us an extension until August 15, 2011 to submit our responses to the Comment Letter.  

Please feel free to contact me or our legal counsel Pryor Cashman LLP, Attn: Elizabeth Chen, Esq. at 1-212-326-0199 or via fax at 1-212-798-6366, in case of any further comments or questions in this regard.

Very truly yours,

/s/ Zhilin Li                             

Zhilin Li

Chief Executive Officer